FrancophonIA/ELRC3.0 huggingface dataset:
English: Carbaglu has also been studied in 57 patients (about two-thirds were newborn babies) with isovaleric acidaemia, methylmalonic acidaemia or propionic acidaemia who were treated with Carbaglu during hyperammonaemia crises.
Estonian: Lisaks uuriti Carbaglud 57 (sh umbes 2/3 vastsündinuid) isovalerüül-atsideemia, metüülmaloonatsideemia ja propioon-atsideemiaga patsiendil, keda raviti Carbagluga hüperammoneemiakriisi ajal.
English: Carbaglu is very similar in structure to N-acetylglutamate, which activates an enzyme that breaks down ammonia.
Estonian: Carbaglu on ehituselt väga sarnane N-atsetüülglutamaadile, mis aktiveerib ammoniaaki lagundavat ensüümi.
English: Patients on Carbaglu could be kept stable without a need for restrictions to the diet or the use of other medicines.
Estonian: Carbaglud saavatel patsientidel saavutati stabiilsus ilma piiranguteta nende toitumises ja ilma teiste ravimiteta.
English: Carbaglu therefore helps break down ammonia, reducing ammonia blood levels and its toxic effects.
Estonian: Seega aitab Carbaglu lagundada ammoniaaki ja vähendab ammoniaagi kontsentratsiooni veres ning vähendab mürgist toimet.
English: Carbaglu should not be used in people who may be hypersensitive (allergic) to carglumic acid or any of the other ingredients.
Estonian: Carbaglud ei tohi kasutada patsiendid, kes võivad olla kargluumhappe või selle ravimi mis tahes muu koostisaine suhtes ülitundlikud (allergilised).
English: Carbaglu is used for the treatment of hyperammonaemia (high blood levels of ammonia) in patients with the following metabolic diseases:
Estonian: Carbaglud kasutatakse hüperammoneemiaga (vere suur ammoniaagisisaldus) patsientide ravimiseks, kellel on järgmised ainevahetushaigused:
English: Carbaglu is a medicine that contains the active substance carglumic acid.
Estonian: Carbaglu on ravim, mis sisaldab toimeainena kargluumhapet.
English: What is the risk associated with Carbaglu?
Estonian: Mis riskid Carbagluga kaasnevad?
English: Carbaglu treatment should be started by a doctor who has experience in treating patients with metabolic diseases.
Estonian: Carbaglu ravi tohib alustada üksnes ainevahetushaigustega patsientide ravis kogenud arst.
English: Carbaglu must not be used in women who are breastfeeding.
Estonian: Carbaglud ei tohi kasutada rasedatel ja imetavatel naistel.
English: In patients with isovaleric acidaemia, methylmalonic acidaemia or propionic acidaemia, Carbaglu also induced a decrease in ammonia levels in the blood, following an average of 5.5 days of treatment.
Estonian: Isovalerüül-atsideemia, metüülmaloon-atsideemia ja propioon-atsideemiaga patsientidel vähendas Carbaglu peale keskmiselt 5,5-päevast ravi ammoniaagi sisaldust veres.
English: In patients with NAGS deficiency, ammonia levels were brought back to normal after Carbaglu treatment.
Estonian: NAGS-i vaegusega patsientidel saavutati Carbaglu ravi järel ammoniaagisisalduse normaliseerumine.
English: The tablets should be dispersed (mixed) in a small amount of water before being given to the patient.
Estonian: Enne patsiendile manustamist tuleb tabletid segada väikese koguse veega.
English: How does Carbaglu work?
Estonian: Kuidas Carbaglu toimib?
English: What benefit has Carbaglu shown during the studies?
Estonian: Milles seisnes uuringute põhjal Carbaglu kasulikkus?
English: The Committee recommended that Carbaglu be given marketing authorisation.
Estonian: Komitee soovitas anda ravimi müügiloa.
English: If the enzyme is not present,
Estonian: Kui see ensüüm puudub, siis ammoniaak ei lagune ja koguneb verre.
English: What is Carbaglu used for?
Estonian: Milleks Carbaglud kasutatakse?
English: • some organic acidaemias (isovaleric acidaemia, methylmalonic acidaemia and propionic acidaemia)
Estonian: • Teatud orgaanilised atsideemiad (isovalerüül-atsideemia, metüülmaloon-atsideemia ja propioon atsideemia), kui patsientidel on valkude metabolismis osalevate teatud ensüümide vaegus.
English: How is Carbaglu used?
Estonian: Kuidas Carbaglud kasutatakse?
English: How has Carbaglu been studied?
Estonian: Kuidas Carbaglud uuriti?
English: It is available as tablets (60 mg).
Estonian: Seda turustatakse tablettidena (60 mg).
English: This summary was last updated in 01-2015.
Estonian: Kokkuvõtte viimane uuendus: 01-2015.
English: The full EPAR for Raloxifene Teva can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Estonian: Euroopa avaliku hindamisaruande täistekst Raloxifene Teva kohta on ameti veebilehel: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: The European Commission granted a marketing authorisation valid throughout the EU for Raloxifene Teva on 29 April 2010.
Estonian: Euroopa Komisjon andis Raloxifene Teva müügiloa, mis kehtib kogu Euroopa Liidu territooriumil, 29. aprillil 2010.
English: Gradually, the bones become thin and fragile, and more likely to break (fracture).
Estonian: Luud muutuvad järkjärgult urbsemaks ja hapramaks ning murduvad kergesti.
English: The recommended dose of Raloxifene Teva is one tablet taken once a day.
Estonian: Raloxifene Teva soovitatav annus on üks tablett üks kord ööpäevas.
English: For more information about treatment with Raloxifene Teva, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Estonian: Kui vajate Raloxifene Tevaga toimuva ravi kohta lisateavet, lugege palun pakendi infolehte (mis on samuti Euroopa avaliku hindamisaruande osa) või pöörduge oma arsti või apteekri poole.
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Raloxifene Teva.
Estonian: Selles selgitatakse, kuidas inimravimite komitee hindas ravimit ja otsustas toetada müügiloa andmist; samuti esitatakse komitee soovitused, kuidas ravimit kasutada.
English: The Committee recommended that Raloxifene Teva be given marketing authorisation.
Estonian: Komitee soovitas anda Raloxifene Teva müügiloa.
English: Raloxifene has the same effect as oestrogen in the bone, but it does not have an effect in the breast or the womb.
Estonian: Raloksifeenil on luudes samasugune toime kui östrogeenil, kuid ei mõju rinnanäärmetele ega emakale.
English: Other information about Raloxifene Teva
Estonian: Muu teave Raloxifene Teva kohta
English: This is a summary of the European Public Assessment Report (EPAR) for Raloxifene Teva.
Estonian: Käesolev dokument on ravimi Raloxifene Teva Euroopa avaliku hindamisaruande kokkuvõte.
English: Because Raloxifene Teva is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine's.
Estonian: Et Raloxifene Teva on geneeriline ravim ja võrdlusravimiga bioekvivalentne, peetakse tema kasulikkust ja riske samadeks mis võrdlusravimil.
English: This means that Raloxifene Teva is similar to a ‘reference medicine' already authorised in the European Union (EU) called Evista.
Estonian: See tähendab, et Raloxifene Teva on sarnane võrdlusravimiga Evista, millel juba on Euroopa Liidus müügiluba.
English: Raloxifene Teva is a medicine that contains the active substance raloxifene hydrochloride.
Estonian: Raloxifene Teva on ravim, mis sisaldab toimeainena raloksifeenvesinikkloriidi.
English: The CHMP concluded that, in accordance with EU requirements, Raloxifene Teva has been shown to have comparable quality and to be bioequivalent to Evista.
Estonian: Inimravimite komitee järeldas, et vastavalt Euroopa Liidu nõuetele on tõendatud ravimi Raloxifene Teva võrdväärne kvaliteet ja bioekvivalentsus ravimiga Evista.
English: The active substance in Raloxifene Teva, raloxifene, is a selective oestrogen receptor modulator (SERM).
Estonian: Raloxifene Teva toimeaine raloksifeen on selektiivne östrogeeni retseptori modulaator (SERM).
English: Raloxifene Teva is a ‘generic medicine'.
Estonian: Raloxifene Teva on geneeriline ravim.
English: Raloxifene Teva raloxifene hydrochloride
Estonian: Raloxifene Teva raloksifeenvesinikkloriid
English: Raloxifene Teva has been shown to significantly reduce vertebral fractures (breaks in the spine), but not hip fractures.
Estonian: On tõendatud, et Raloxifene Teva vähendab oluliselt lülisambamurde, kuid mitte reieluukaelamurde.
English: Therefore, the CHMP's view was that, as for Evista, the benefit outweighs the identified risk.
Estonian: Seetõttu arvas inimravimite komitee, et nagu ka Evista korral, ületab Raloxifene Teva kasulikkus sellega kaasnevad riskid.
English: What is Raloxifene Teva?
Estonian: Mis on Raloxifene Teva?
English: Patients may also receive calcium and vitamin D supplements if they do not get enough from their diet. Raloxifene Teva is intended for long-term use.
Estonian: Kui patsient ei saa toidust piisavalt kaltsiumi ja D-vitamiini, tuleb võtta neid täiendavalt.
English: Because Raloxifene Teva is a generic medicine, studies in people have been limited to tests to determine that it is bioequivalent to the reference medicine, Evista.
Estonian: Et Raloxifene Teva on geneeriline ravim, piirdusid patsiendiuuringud katsetega, milles näidati ravimi Raloxifene Teva bioekvivalentsust võrdlusravimiga Evista.
English: Why has Raloxifene Teva been approved?
Estonian: Miks Raloxifene Teva heaks kiideti?
English: Raloxifene acts as an ‘agonist' of the oestrogen receptor (a substance that stimulates the receptor for oestrogen) in some tissues in the body.
Estonian: Raloksifeen toimib mõnes organismi koes östrogeeni retseptori agonistina (stimuleerib östrogeeni retseptorit).
English: Raloxifene Teva is used for the treatment and prevention of osteoporosis (a disease that makes bones fragile) in women who have been through the menopause.
Estonian: Raloxifene Tevat kasutatakse menopausijärgses eas naistel osteoporoosi (luu-urbnemuse) raviks ja ennetamiseks.
English: How has Raloxifene Teva been studied?
Estonian: Kuidas Raloxifene Tevat uuriti?
English: What are the benefit and risk of Raloxifene Teva?
Estonian: Milles seisneb Raloxifene Teva kasulikkus ja mis riskid ravimiga kaasnevad?
English: How is Raloxifene Teva used?
Estonian: Kuidas Raloxifene Tevat kasutatakse?
English: What is Raloxifene Teva used for?
Estonian: Milleks Raloxifene Tevat kasutatakse?
English: How does Raloxifene Teva work?
Estonian: Kuidas Raloxifene Teva toimib?
English: The medicine can only be obtained with a prescription.
Estonian: Raloxifene Teva on retseptiravim.
English: Please carefully follow the instructions of the veterinarian.
Estonian: Palun järgige hoolikalt loomaarsti antud juhiseid.
English: Store in the original package in order to protect from light.
Estonian: Hoida originaalpakendis, et kaitsta valguse eest.
English: If more than 50 broachings are required, the use of a draw-off needle is recommended.
Estonian: Kui üle 50 korra läbistamine on vajalik soovitatakse kasutada draw-off nõela.
English: Povidone K30
Estonian: Povidoon K30
English: 10 tablets 20 tablets 100 tablets 500 tablets
Estonian: 10 tabletti 20 tabletti 100 tabletti 500 tabletti
English: A clinical response is normally seen within 3-4 days.
Estonian: Tavaliselt ilmneb kliiniline vastus 3-4 päevaga.
English: Date of first authorisation: 10/02/2009 Date of last renewal: 23/01/2019
Estonian: Esmase müügiloa väljastamise kuupäev: 10/02/2009 Müügiloa viimase uuendamise kuupäev: 23/01/2019
English: Acute respiratory infection.
Estonian: Äge respiratoorne infektsioon.
English: Any unused half tablets may be returned to open blister and stored for up to 24 hours.
Estonian: Kasutamata poolikuid tabletid võib panna tagasi avatud blistrisse ja hoiustada kuni 24 tundi.
English: Milk: 5 days
Estonian: Piimale: 5 päeva.
English: Treatment of calves with Loxicom 20 minutes before dehorning reduces post-operative pain.
Estonian: Vasikate ravi Loxicomiga 20 minutit enne sarvede eemaldamist vähendab operatsioonijärgset valu.
English: ATCvet code: QM01AC06
Estonian: ATCvet kood: QM01AC06
English: The tablets can be broken into equal halves.
Estonian: Tablette saab poolitada võrdseteks osadeks.
English: If skin and/or eye contact occurs, wash the affected parts immediately with water.
Estonian: Nahale ja/või silma sattumisel loputage kahjustatud piirkondi kohe veega.
English: 21 % of the recovered dose is eliminated in urine (2 % as unchanged meloxicam, 19 % as metabolites) and 79 % in the faeces (49 % as unchanged meloxicam, 30 % as metabolites).
Estonian: 21% manustatud annusest eritub uriiniga (2% muutumatul kujul meloksikaamina, 19% metaboliitidena) ja 79% väljaheitega (49% muutumatul kujul meloksikaamina, 30% metaboliitidena).
English: The tablets can be administered with or without food, are flavoured and are taken by most dogs voluntarily.
Estonian: Tablette võib anda kas koos toiduga või ilma, need on maitsestatud ning enamik koeri võtavad neid vabatahtlikult.
English: BN {number}
Estonian: Lot {number}
English: Maximal plasma concentrations are obtained after approximately 2 - 3 hours.
Estonian: Maksimaalsed plasmakontsentratsioonid saavutatakse ligikaudu 2-3 tunni pärast.
English: CONTENTS BY WEIGHT, BY VOLUME OR BY NUMBER
Estonian: PAKENDI SISU KAALU, MAHU VÕI ANNUSTE ARVU JÄRGI
English: A pale yellow homogenous paste.
Estonian: Helekollane homogeenne pasta.
English: The metabolism in horses has not been investigated.
Estonian: Metabolismi hobustel ei ole uuritud.
English: Co. Down, BT35 6PU United Kingdom
Estonian: Co. Down, BT35 6PU Ühendkuningriik
English: In the case of overdose, adverse reactions (as listed in Section 4.6) are expected to be more severe and more frequent.
Estonian: Üleannustamise korral võivad (lõigus 4.6. loetletud) kõrvaltoimed olla raskemad ja sagedasemad.
English: Do not exceed 50 broachings per vial.
Estonian: Mitte läbistada viaali korki üle 50 korra.
English: To be administered directly into the mouth over the back of the tongue keeping the animal's head raised until swallowed.
Estonian: Manustada otse suhu üle keelepära, hoides looma pead kõrgemal kuni neelamiseni.
English: Therefore the use in this species is not recommended during pregnancy and lactation.
Estonian: Seetõttu ei ole kasutamine sellel loomaliigil tiinuse ja laktatsiooni ajal soovitatav.
English: The safety of the veterinary medicinal product has not been established during pregnancy and lactation (see section 4.3).
Estonian: Veterinaarravimi ohutus tiinuse ja laktatsiooni perioodil ei ole piisavalt tõestatud (vt lõik 4.3.
English: Not authorised for use in horses producing milk for human consumption.
Estonian: Ei ole lubatud kasutada lakteerivatel hobustel, kelle piima tarvitatakse inimtoiduks.
English: When the product is used according to the recommended dosage regime the oral bioavailability is approximately 98%.
Estonian: Ravimi kasutamisel soovitatava annustamisskeemi kohaselt on suukaudne biosaadavus ligikaudu 98%.
English: Laboratory studies in cattle have not provided any evidence for teratogenic, foetotoxic, or maternotoxic effects.
Estonian: Laboratoorsed uuringud veistega ei ole näidanud teratogeenset, fetotoksilist ega maternotoksilist toimet.
English: See also section 4.3.
Estonian: Vt ka lõiku 4.3.
English: As for other species investigated, the main pathway of meloxicam biotransformation in cat is oxidation.
Estonian: Nagu teiste uuritud loomaliikide puhul, on meloksikaami biotransformatsiooni peamiseks teeks kassidel oksüdatsioon.
English: АСКЛЕП - ФАРМА ООД гр.
Estonian: Република България АСКЛЕП - ФАРМА ООД гр.
English: The active substance in Loxicom 20 mg/ml solution for injection for cattle, pigs and horses is an allowed substance as described in table 1 of the annex to Commission Regulation (EU) No 37/2010:
Estonian: Loxicom 20 mg / ml süstelahuse veistele, sigadele ja hobustele toimeaine on lubatud aine, nagu on kirjeldatud komisjoni määruse (EL) nr 37/2010 lisa tabelis 1:
English: See section "Contraindications".
Estonian: vt lõik „Vastunäidustused“.
English: The metabolism is qualitatively similar in rats, mini-pigs, humans, cattle and pigs although quantitatively there are differences.
Estonian: Rottidel, minisigadel, inimestel, veistel ja sigadel on metabolism kvalitatiivselt sarnane, kuigi selles on kvantitatiivseid erinevusi.
English: When anaesthesia and NSAID are concomitantly administered, a risk for renal function cannot be excluded.
Estonian: Kui korraga manustatakse NSAIDe ja anesteesiat, ei saa välistada riski neerude funktsioonile.
English: The suspension can be given using either of the two measuring syringes provided in the package (depending on weight of dog).
Estonian: Suspensiooni võib manustada pakendis oleva kahe annustamissüstla abil (sõltuvalt koera kaalust).
English: Meloxicam is eliminated with a half-life of 24 hours in dogs and 15 hours in cats.
Estonian: Meloksikaami elimineerumise poolväärtusaeg on 24 tundi koertel ja 15 tundi kassidel.
English: However, no data have been generated in horses.
Estonian: Hobuste kohta siiski andmed puuduvad.
English: To ensure correct dosage, bodyweight should be determined as accurately as possible to avoid underdosing or overdosing.
Estonian: Tagamaks manustamine korrektses doosis, tuleb aladoseerimise või üledoseerimise vältimiseks kehakaal määrata võimalikult täpselt.
English: To ensure administration of a correct dose, body weight should be determined as accurately as possible.
Estonian: Tagamaks manustamine korrektses doosis, tuleb kehakaal määrata võimalikult täpselt.
English: The detection of metabolites from the parent compound in urine and faeces, but not in plasma is indicative for their rapid excretion.
Estonian: Meloksikaami metaboliitide esinemine uriinis ja väljaheites, aga mitte plasmas, viitab nende kiirele eritamisele.
English: Do not exceed the recommended dose or duration of treatment due to the possibility of severe adverse reactions.
Estonian: Mitte ületada soovitatavat annust ega ravi kestust raskete kõrvaltoimete võimaliku ohu tõttu.
English: This veterinary medicinal product for dogs should not be used in cats as it is not suitable for use in this species.
Estonian: Seda koertele mõeldud veterinaarravimit ei tohi kasutada kassidel, kuna see ei sobi sellele liigile.
English: Post-operative pain and inflammation following surgical procedures: In case additional pain relief is required, multimodal pain therapy should be considered.
Estonian: Operatsioonijärgne valu ja põletik pärast kirurgilisi protseduure: täiendava valuvaigisti vajaduse korral tuleb kaaluda täiendavalt muu valuvaigisti kasutamist.
English: For post-operative pain relief in cats, safety has only been documented after thiopental/halothane anaesthesia.
Estonian: Postoperatiivse valu leevendamiseks kassidel on ohutus määratletud vaid tiopentaal/halotaan anesteesia korral.
English: Administer 0.6 mg/kg body weight, once daily for up to 14 days.
Estonian: Manustada 0,6 mg kehamassi 1 kg kohta üks kord päevas kuni 14 päeva vältel.
English: Acute mastitis.
Estonian: Äge mastiit.
English: Do not store above 25°C.
Estonian: Mitte hoida temperatuuril üle 25°C.
English: Chronic musculoskeletal disorders: Response to long-term therapy should be monitored at regular intervals by a veterinary surgeon.
Estonian: Kroonilised lihas-skeleti kahjustused: Loomaarst peab regulaarselt jälgima reageerimist pikaajalisele ravile.
English: Five major metabolites were detected all having been shown to be pharmacologically inactive.
Estonian: Viis tähtsamat metaboliiti on osutunud farmakoloogiliselt inaktiivseteks.
English: In vitro and in vivo studies demonstrated that meloxicam inhibits cyclooxygenase-2 (COX-2) to a greater extent than cyclooxygenase-1 (COX-1).
Estonian: In vitro ja in vivo uuringutes näitas meloksikaam tsüklooksügenaas-2 (COX-2) suhtes tugevamat inhibeerivat toimet kui tsüklooksügenaas-1 (COX-1) suhtes.
English: In animals at anaesthetic risk (e.g. aged animals) intravenous or subcutaneous fluid therapy during anaesthesia should be taken into consideration.
Estonian: Loomadel, kellele anesteesia on risk (näiteks vanad loomad) tuleks kaaluda intravenoosse või subkutaanse vedelikteraapia teostamist enne anesteesiat.
English: A yellow solution.
Estonian: Kollane lahus.
English: If required, a second administration can be given after 24 hours.
Estonian: Vajadusel võib ravi 24 tunni pärast korrata.
English: Dogs: intravenous or subcutaneous use.
Estonian: Koerad: intravenoosne või subkutaanne manustamine.
English: This product for dogs should not be used in cats due to the different dosing devices.
Estonian: Seda koertele mõeldud preparaati ei tohi kasutada kassidel erinevate mõõteseadmete tõttu.
English: Particular care should be taken with regard to the accuracy of dosing.
Estonian: Eriti hoolikalt tuleb jälgida annustamise täpsust.
English: Oral Suspension.
Estonian: Suukaudne suspensioon.
English: Sodium hydroxide (for pH adjustment) Hydrochloric acid (for pH adjustment) Water for injection
Estonian: Naatriumhüdroksiid (pH kohandamiseks) HVesinikkloriidhape (pH kohandamiseks) Süstevesi
English: Accidental self injection may cause pain.
Estonian: Juhuslik süstimine iseendale võib tekitada valu.
English: Low-density polyethylene pre-filled syringes containing 8.4 g of product in cartons of 1, 7, or 14 syringes.
Estonian: Madaltihedast polüetüleenist süstelid, mis sisaldavad 8,4 g ravimit, karbis on 1, 7 või 14 süstelit.
English: The major metabolites found in all species were the 5-hydroxyand 5-carboxy-metabolites and the oxalyl-metabolite.
Estonian: Kõikidel loomaliikidel leiti põhiliste metaboliitidena 5-hüdroksü- ja 5karboksü-metaboliite ja oksalüül-metaboliiti.
English: Post-operative pain and inflammation following surgical procedures:
Estonian: Operatsioonijärgne valu ja põletik pärast kirurgilisi protseduure:
English: In very rare cases anaphylactoid reactions may occur and should be treated symptomatically.
Estonian: Väga harvadel juhtudel võib esineda anafülaktilisi reaktsioone, mida tuleks ravida sümptomaatiliselt.
English: Cats: subcutaneous use.
Estonian: Kassid: subkutaanne manustamine.
English: Treatment should be discontinued after 10 days if no clinical improvement is apparent.
Estonian: Ravi tuleb lõpetada 10 päeva pärast juhul, kui kliinilist paranemist ei ilmne.
English: To a minor extent it also inhibits collagen-induced thrombocyte aggregation.
Estonian: See pärsib vähemal määral ka kollageenist indutseeritud trombotsüütide agregatsiooni.
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS
Estonian: MINIMAALSED ANDMED, MIS PEAVAD OLEMA ÄRA MÄRGITUD BLISTER -VÕI RIBAPAKENDIL
English: Loxicom 0.5 mg/ml Oral Suspension for Cats is available in bottle of 5 ml, 15 ml and 30 ml volumes.
Estonian: Loxicom 0,5 mg/ml suukaudne suspensioon kassidele on saadaval 5 ml, 15 ml ja 30 ml pudelites.
English: Each ml contains:
Estonian: Iga ml sisaldab:
English: Česká republika/ Slovenská republika SSamohýl group a.s.
Estonian: Slovenská republika Samohýl group a.s.
English: The recommended maximum volume to be administered at a single injection site is 10 ml.
Estonian: Soovitatav maksimaalne kogus ühte süstekohta manustamiseks on 10 ml.
English: Any unused medicines or waste materials should not be disposed of via wastewater or household waste but in accordance with local requirements.
Estonian: Kasutamata jäänud ravimeid ega jäätmematerjali ei tohi ära visata kanalisatsiooni kaudu ega koos majapidamisprügiga, vaid tuleb hävitada vastavalt kohalikule seadusandlusele.
English: In this case do not use oral follow up treatment.
Estonian: Sel juhul mitte kasutada suukaudset järelravi.
English: Other NSAIDs, diuretics, anticoagulants, aminoglycoside antibiotics and substances with high protein binding may compete for binding and thus lead to toxic effects.
Estonian: Teised mittesteroidsed põletikuvastased ravimid, diureetikumid, antikoagulandid, aminoglükosiidid ja proteiinidega hästi seonduvad ained võivad seondumiseks omavahel konkureerida ja tekitada toksilist toimet.
English: Treatment should be discontinued after 10 days at the latest if no clinical improvement is apparent.
Estonian: Ravi tuleb lõpetada hiljemalt 10 päeva pärast juhul, kui kliinilist paranemist ei ilmne.
English: Should irritation occur and persist, seek medical advice.
Estonian: Ärrituse tekkimisel ja püsimisel pöörduda arsti poole.